Overview

Clinical Study of Umbilical Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Traumatic Fracture Healing

Status:
Recruiting
Trial end date:
2022-12-10
Target enrollment:
Participant gender:
Summary
The aim of this study is to explore the effectiveness and safety of umbilical cord blood mononuclear cells in promoting traumatic fracture healing.
Phase:
N/A
Details
Lead Sponsor:
Qianfoshan Hospital
Collaborator:
Shandong Qilu Stem Cells Engineering Co., Ltd.